title: [Managing inflammatory bowel disease in the biologics era: treating beyond symptoms is not sufficient].
authors: Laurent
authors: L
authors: Peyrin-Biroulet
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001688:Biological Products / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab; D058990:Molecular Targeted Therapy; D010166:Palliative Care / Q000639:trends; D018802:Patient-Centered Care / Q000639:trends; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; C543529:vedolizumab; D000069285:Infliximab